SCHEMBL14256553

SCHEMBL14256553

O=[N+]([O-])c1ccc(N2CCN(c3nc(NC4CCCC4)c4ccccc4n3)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR4 P51679 1/20 0.60
▸ DNMT3A Q9Y6K1 4/20 0.56
▸ ABCG2 Q9UNQ0 2/20 0.55
▸ ALDH1A1 P00352 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ HTT P42858 3/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ TP53 P04637 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256570 0.84 CCR4 (0.65) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL14256555 0.84 CCR4 (0.65) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL14266666 0.83 CCR4 (0.65) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL14256565 0.82 MEN1 (0.61) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL14256631 0.79 CCR4 (0.71) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL14256456 0.79 ALDH1A1 (0.62) CCR4DNMT3AABCG2ALDH1A1MAPT
SCHEMBL30896243 0.78 CCR4 (0.73) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL11743074 0.78 CCR4 (0.73) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL14256594 0.77 CCR4 (0.71) CCR4DNMT3AALDH1A1MAPTHTT
SCHEMBL12134743 0.77 KMT2A (0.62) ABCG2ALDH1A1MAPTHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF CCR4 467/4885DNMT3A 832/4885ABCG2 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback